- Home
- GOVX vs KXIN Comparison
GOVX vs KXIN Comparison
Compare GOVX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- KXIN
- Stock Information
- Founded
- GOVX 2001
- KXIN 2015
- Country
- GOVX United States
- KXIN China
- Employees
- GOVX N/A
- KXIN N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- GOVX Health Care
- KXIN Consumer Discretionary
- Exchange
- GOVX Nasdaq
- KXIN Nasdaq
- Market Cap
- GOVX 15.5M
- KXIN 13.0M
- IPO Year
- GOVX N/A
- KXIN N/A
- Fundamental
- Price
- GOVX $0.95
- KXIN $0.91
- Analyst Decision
- GOVX Strong Buy
- KXIN
- Analyst Count
- GOVX 5
- KXIN 0
- Target Price
- GOVX $12.40
- KXIN N/A
- AVG Volume (30 Days)
- GOVX 1.5M
- KXIN 53.4K
- Earning Date
- GOVX 08-05-2025
- KXIN 01-01-0001
- Dividend Yield
- GOVX N/A
- KXIN N/A
- EPS Growth
- GOVX N/A
- KXIN N/A
- EPS
- GOVX N/A
- KXIN N/A
- Revenue
- GOVX $5,591,576.00
- KXIN N/A
- Revenue This Year
- GOVX N/A
- KXIN N/A
- Revenue Next Year
- GOVX N/A
- KXIN N/A
- P/E Ratio
- GOVX N/A
- KXIN N/A
- Revenue Growth
- GOVX N/A
- KXIN N/A
- 52 Week Low
- GOVX $0.73
- KXIN $0.64
- 52 Week High
- GOVX $11.18
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- GOVX 46.22
- KXIN 52.51
- Support Level
- GOVX $0.85
- KXIN $0.84
- Resistance Level
- GOVX $1.39
- KXIN $0.96
- Average True Range (ATR)
- GOVX 0.15
- KXIN 0.05
- MACD
- GOVX -0.02
- KXIN 0.00
- Stochastic Oscillator
- GOVX 18.52
- KXIN 63.64
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.